Undersea Technology Innovation Consortium members awarded $600 million in prototype project funding
Since UTIC’s inception in 2018, $600 million in prototype project funding has been awarded to members.
Since UTIC’s inception in 2018, $600 million in prototype project funding has been awarded to members.
The DBMIP will execute investments through the Defense Industrial Base Consortium (DIBC) Other Transaction Agreement (OTA), which helps lower barriers to allow DoD to work more expeditiously with small, non-traditional, and large businesses.
Advanced Technology International (ATI) has been awarded an Other Transaction (OT) Agreement by the Department of Defense to establish and manage the Defense Industrial Base Consortium (DIBC).
The Naval Surface Technology & Innovation Consortium (NSTIC) today announces it has grown to over 1,000 members since its inception in 2019.
MTEC member and small business SurgiBox Inc. is an inventor of surgical kits that allow doctors to perform life-saving surgeries anywhere – even in the middle of war zones or other hostile situations.
Advanced Technology International (ATI) has been awarded an Other Transaction Agreement (OTA) by the Naval Surface Warfare Center, Crane Division (NSWC Crane) to serve as the consortium manager for the Expeditionary Missions Consortium - Crane.
The Advanced Weapons Technology Summit, which will be Nov. 1-3 in the Saturn Ballroom, will feature senior Department of Defense leader presentations on warfighter and industrial base priorities.
Resodyn Corporation received a $13.2 Million (USD) award under the Naval Energetic Systems and Technologies (NEST) Other Transaction Agreements (OTA) Program (https://www.nswcihdnest.org/awards/).
Advanced Technology International (ATI) has been awarded an Other Transaction Agreement (OTA) by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to serve as the consortium manager for the Rapid Response Partnership Vehicle (RRPV).
The Partial REBOA Outcomes Multicenter Prospective Trial (PROMPT) was selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly $6 million in funding from the U.S. Department of Defense grant awarded through the Medical Technology Enterprise Consortium (MTEC).